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Ferulic acid (FA) is a polyphenolic compound with demonstrated antioxidant capacity. In this study, propionyl 
ferulate (PF) was synthesized and characterized using melting point, ultraviolet spectroscopy, Fourier-transform 
infrared spectroscopy, and mass spectrometry. The propionyl ferulate was comparatively evaluated for antioxidant 
potential which included the ability to quench reactive species of 2,2-diphenyl-2-picrazyl-hydrazyl (DPPH), hydroxyl, 
nitric oxide, and superoxide anion. In addition, the total antioxidant capacity and membrane stabilizing properties of 
the ferulate were determined. Comparatively, the spectroscopically characterized PF showed superior scavenging 
capacity for the DPPH, hydroxyl, and nitric oxide free radicals when compared to FA. On the contrary, PF showed a 
poor scavenging capacity for superoxide anion radicals. Furthermore, PF showed little or no potential for membrane 
stability. In conclusion, the data suggest that structurally modifying FA to PF improved the antioxidant capacity for 
several free radicals.
INTRODUCTION
Antioxidants are chemical or molecular substances that 
delay or arising from the action of reactive oxygen or nitrogen 
species (ROS/RNS). They function by electron donation, metal 
ion chelation, antioxidation, or gene expression regulation. 
Antioxidants have displayed therapeutic potential in several 
ailments, such as neurodegenerative diseases, cardiovascular and 
cancer (Kim et al., 2003; Soobrattee et al., 2005) resulting in 
rapidly increasing interest in their medicinal application (Wang 
and Lin, 2000). In addition, the demand for antioxidants in various 
manufacturing processes, particularly the food industry, has been 
on the increase, leading to the production of synthetic antioxidants 
to match this demand. However, in recent years, there has been 
a shift from synthetic to natural antioxidants (Adeyemi et al., 
2018). The preference for the use of natural antioxidants stems 
from the belief that they have lower toxicity than their synthetic 
counterparts.
Polyphenolic compounds are naturally occurring 
antioxidants that are ubiquitous in plant and vegetable diets 
(Clifford, 1999; Pimentel et al., 2005). This class of natural 
compounds has also received interest within the past decade 
as a result of their therapeutic prospects, particularly against 
cardiovascular-related diseases and cancer (Nardini, 2004). Ferulic 
acid (4-hydroxy-3-methoxycinnamic acid) (FA), is a natural 
phenolic and it is one of the most abundant phenols in many plants 
(D'Archivio et al., 2007; Rechner et al., 2001). FA occurs freely, or 
in dimers, or as esters bound to polysaccharides or proteins in cell 
walls, such as arabinoxylan in grass and xyloglucan in bamboo 
(Fazary and Ju, 2007; Rumbold et al., 2003). FA consists of a 
hydroxyl, carboxyl, and methoxy group, an ethylenic bond, and 
a benzene ring (Zhang et al., 2003). The chemical features of FA 
have been exploited in the synthesis of diverse derivatives such as 
esters, ethers, amides, anhydrides, acyl chlorides, acid polymers, 
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nitrobenzenes, benzene sulfonic acids, and benzene halides of 
FA (Zhang et al., 2003). The scavenging properties of FA may be 
attributed in presence of electron-donating groups; 3-methoxy and 
4—hydroxyl (Kanasaki et al., 2002). One of these characteristics 
is the presence of the electron-donating groups on the ring 
structure (3-methoxy and 4-hydroxyl). The second is the presence 
of a carboxylic acid group adjacent to an unsaturated carbon-
carbon double bond (Kanasaki et al., 2002). The carboxylic acid 
group also provides support, through which it binds to membrane 
bilayers, thereby preventing lipid peroxidation (Kanasaki et al., 
2002). Furthermore, FA has the capacity to negate radical chain 
reactions through polymerization and is known to increase cross-
linkages in polysaccharides and other polymers, giving it capacity 
to prevent UV-radiation damage (dos Santos et al., 2008).
Although FA has been shown to have a low toxicity 
index relative to its various biological and medicinal activities, its 
clinical use is still underexplored. Its use is greatly limited by the 
fact that it is unstable in different solvents and has a low interaction 
with lipids (Compton et al., 2012; Qin et al., 2013; Stamatis et al., 
2001). Therefore, the focus has shifted to the use of FA derivatives 
as possible alternatives to FA due to their lipophilic properties. In 
this study, we synthesized propionyl ferulate (PF) and evaluated 
the antioxidant potential of the derivative compared with FA.
MATERIALS AND METHODS
Experimental
Analytical grade reagents used included FA and 
L-ascorbic acid (Sigma-Aldrich, St. Louis, MO). The monitoring 
of reaction and purity check were accomplished by thin-layer 
chromatography (TLC) on precoated silica gel (0.25 mm 60 F254 
plates, Merck, Germany) and observed in UV light (254 and 365 
nm). A stock solution (2 mg/ml) of PF or FA was prepared in 
methanol.
Synthesis of PF
First, the reaction was initiated by dissolving 0.97 g of 
FA (5 mmol, 194 g) in 5% NaOH (aq). After 30 min of continuous 
stirring on ice (10oC) the resulting solid was collected via filtration 
and washed with cold saturated brine solution to purify (Scheme 1). 
The product obtained was dried at room temperature.
Propionyl ferulate
It is a white powder, having m.p. 162-164oC, yield 37%, 
(Rf is 0.60 in dichloromethane), (λmax is 321 nm with 2.5 abs), IR 
using the KBr pellet method; Vmax, cm
-1 - 3437, 2939, 2366, 1687, 
1625, 1425, 1126; C13H14O5; MW=250.25; MS: m/z (%): 150, 135, 
118, 107.
The melting point was obtained by using a melting point 
apparatus (Electrothermal, UK), whereas absorption data were 
recorded by using a UV-VIS spectrophotometer (Beckman Coulter 
DU 730 Life Sciences, UK). The infrared spectrum was obtained by 
the KBr pellet protocol on a Shimadzu (8400S) Fourier-transform 
infrared spectrometer. The molecular weight was estimated by 
mass spectrometry in ionization mode at 70 eV (MS-QP 2010 
PLUS, Shimadzu, Japan), with Finnigan MAT ion trap detector.
In vitro antioxidant screening
Assay for 2,2-diphenyl-2-picryl-hydrazyl (DPPH) scavenging 
potential
The DPPH radical scavenging assay was performed in 
line with the method described by Devi et al. (2011). An aliquot 
(0.1 ml) of PF, FA, or L-ascorbic acid (concentration range: 0.01, 
0.05, and 0.1 µg/ml, respectively) was added to 2.9 ml of 0.1 mM 
DPPH-methanol. After 30 min of vigorous shaking and incubation 
in the dark, the absorbance of mixture was read at 517 nm on a 
spectrophotometer (Jenway, Staffordshire, UK). The control 
contained 0.1 ml of methanol and 2.9 ml of DPPH, whereas 
methanol only was used as blank. The % activity was estimated 
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Assay for nitric oxide radical scavenging potential
The nitric oxide radical scavenging assay was carried 
out as described by Ilavarasan et al.. (2005). An aliquot (0.5 ml) 
of PF, FA, or L-ascorbic acid (concentration range: 0.01, 0.05, 
and 0.1 µg/ml, respectively) was added to 0.5 ml of sodium 
nitroprusside. This mixture was incubated for 5 hours at 25°C. 
Thereafter, 0.5 mL of the incubated mixture was added to 0.5 mL 
of Greiss reagent, and the absorbance was read at 540 nm on UV/
VIS spectrophotometer. The blank contained 0.5 ml of distilled 
water, 0.5 ml of sodium nitroprusside, and 0.5 ml of Griess reagent 
and had an absorbance of 540 nm. The following expression was 
used to estimate the % activity:
− ×=%Activity {(Abs control Abs sample)}
(Abs control)
100
Assay for superoxide anion scavenging potential
This assay was carried out using as described elsewhere 
(Luo et al., 2002). Briefly, 1 mL of PF, FA, or L-ascorbic acid 
(concentration range: 0.01, 0.05, and 0.1 µg/mL) was added to 
4.5 mL of Tris-HCl buffer. After 20 min incubation at 25˚C, 0.4 
mL of pyrogallol was added and reaction allowed for 4 min. This 
was followed by termination of reaction with 0.1 mL of HCl. The 
mixture was pelleted at 1,000 g for 15 minutes (model C5, LW 
Scientific, GA), and the absorbance at 325 nm was recorded on 
UV/VIS spectrophotometer.
The blank contained 1ml of distilled water, 4.5 ml of 
Tris-HCl buffer, 0.4 ml of pyrogallol, and 0.1 ml of HCl. The % 
activity was estimated using the following expression:
− ×=%Activity {(Abs control Abs sample)}
(Abs control)
100
Assay for total antioxidant capacity
The assay was performed as described previously 
(Saha et al., 2019). Briefly, 0.3 ml of PF, FA, or L-ascorbic acid 
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(concentration range: 0.01, 0.05, and 0.1 µg/ml, respectively) 
was added to 3 ml of reagent solution (0.6 M sulfuric acid, 28 
mM sodium phosphate, and 4 mM ammonium molybdate). This 
mixture was incubated at 95oC for 90 minutes. This was followed 
by cooling mixture at room temperature and recording the 
absorbance at 695 nm on a spectrophotometer against a blank. For 
control, methanol was used instead of the PF or FA and the activity 
was expressed as gram equivalents of L-ascorbic acid.
Assay for membrane stabilizing effect
This assay was done following a method described by 
Malomo et al. (2011). The assay mixture consisted of 2 ml of 
hyposaline, 1 ml of phosphate buffer, erythrocyte suspension in 
1.5 ml of isosaline, and 1 ml of PF, FA, or reference compound 
(concentration range: 0.01, 0.05 and 0.1 µg/ml, respectively). The 
control lacked the drug or test samples, whereas the drug control 
and test samples lacked the erythrocyte suspension. Isosaline was 
added to the controls to make the reaction volumes up to 4.5 ml. 
After 30 min of incubation at 56˚C, the mixture was cooled and 
pelleted at 1000 g for 15 min. 
The absorbance of the supernatant was read at 560 nm on 
UV/VIS spectrophotometer. The % membrane stabilizing activity 













Results were analyzed by a one-way ANOVA (GraphPad 
Prism 5, CA, USA) and are presented as the mean of replicates ± 
standard error of mean (SEM). The Tukey’s post-Hoc was used 
for multiple comparisons and level of significance was taken at 
p < .05.
RESULTS
Synthesis and characterization of PF
The synthesis of PF was accomplished by treating 
FA dissolved in sodium hydroxide with propionic anhydride. 
The intermediate sodium salt of FA facilitated the reaction with 
propionic anhydride. The reaction was monitored by TLC and 
reached completion in 30 minutes.
The infrared spectrum of the product obtained (PF), a 
white powder with a melting point of 162oC–164oC, showed strong 
absorption bands at 3,437 and 1,687 cm−1 corresponding to OH and 
CO stretching vibrations, respectively Supplementary data.
In vitro antioxidant assays
The comparative evaluation for the in vitro antioxidant 
potential showed that PF had better scavenging properties against 
DPPH, hydroxyl, and nitric oxide radicals compared with FA 
(Figs. 1–3). At all concentrations, PF showed superior scavenging 
activity against DPPH compared with FA or L-ascorbic acid. 
Similarly, PF at 0.01 and 0.05 µg/ml exhibited better scavenging 
activity against the hydroxyl radical compared with FA or 
L-ascorbic acid. In addition, PF showed a strong nitric oxide 
radical scavenging activity compared with FA or L-ascorbic 
acid. On the contrary, FA showed a greater scavenging activity 
against the superoxide anion (Fig. 4). FA also had a higher 
total antioxidant and membrane-stabilizing capacity than PF 
(Figs. 5 and 6). Meanwhile, acetylsalicylic acid which was 
positive drug control for the membrane stability assay showed 
better membrane stability than either FA or PF. Indeed, PF showed 
the least membrane-stabilizing capacity across all concentrations.
Figure 1. DPPH radical scavenging activity of propionyl ferulate, ferulic acid, 
and L-ascorbic acid (standard). Data are expressed as the mean of three replicates 
± SEM. α is significant at p < 0.05 versus ferulic acid and/or L-ascorbic acid.
Figure 2. Hydroxyl radical scavenging activity of propionyl ferulate, ferulic 
acid, and L-ascorbic acid (standard). Data are expressed as the mean of 
three replicates ± SEM. α is significant at p < 0.05 versus ferulic acid and/or 
L-ascorbic acid.
Figure 3. Nitric oxide radical scavenging activity of propionyl ferulate, 
ferulic acid, and L-ascorbic acid (standard). Data are expressed as the mean of 
three replicates ± SEM. α is significant at p < 0.05 versus ferulic acid and/or 
L-ascorbic acid.
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DISCUSSION
Various methods have been used to synthesize the esters 
of phenolics to improve their bioactivity (Hosoda et al., 2002; Zhao 
et al., 2015). The strong hydrophobicity of FA, a hydroxycinnamic 
acid, has necessitated the synthesis of derivatives with improved 
bioactivity and reduced toxicity (Anselmi et al., 2005; Nyaradzo 
et al., 2009; Rakotondramanana et al., 2007). The synthesis of the 
PF was accomplished following a standard procedure (Adeyemi 
et al., 2019). The PF synthesized and characterized in this study 
had UV, IR, and MS data that conform to the indicated structure.
To maximize the antioxidant and/or medicinal value 
of FA and to circumvent its physicochemical and biological 
disadvantages, researchers previously synthesized several 
derivatives (Adeyemi et al., 2018; 2019). In this study, we 
synthesized PF and comparatively evaluated it for antioxidant 
potential. The data indicate that PF showed a superior antioxidant 
capacity to either FA or ascorbic acid. It also had a superior 
scavenging activity for the DPPH radical compared to FA or 
ascorbic acid. This finding differs from the previous study 
(Karamac et al., 2005) which showed that FA had a better 
antioxidant capacity than its derivatives. In addition, PF showed 
better scavenging capacity for hydroxyl and nitrogen radicals 
when compared with FA or ascorbic acid. These findings combine 
to indicate that structurally modifying FA to form PF did not 
compromise its antioxidant potential. This is consistent with the 
previous findings (Adeyemi et al., 2018), in which FA derivatives 
showed superior antioxidant activity compared with FA.
The superior total antioxidant and membrane-stabilizing 
capacity observed with FA over PF might be attributable to the 
polarity of the assay method; thus, since PF is less polar, its 
functional properties may be inaccessible in the assay. Further 
experiments are needed to confirm this speculation. PF’s poor 
capacity for membrane stabilization could also be due to its 
lower hydrophobicity than FA. In this scenario, the reduced 
hydrophobicity of PF might decrease its interaction with the 
membrane in the lipid phase, thereby limiting its capacity to offer 
protection in this phase. This line of thought is further reinforced 
by the finding that FA showed considerable membrane protection. 
Meanwhile, FA had better total antioxidant capacity as well as 
higher scavenging activity for superoxide anion radicals compared 
with PF. This may not be unexpected since FA possesses strong 
antioxidant potential (Kanski et al., 2002).
FA, which is a monohydrated cinnamic acid, can form 
derivatives with distinct structural orientations. Thus, evaluating 
its derivatives is essential to discover the changes in biological 
activity (Calheiros et al., 2009). Of the various approaches for 
synthesizing compounds from FA, esterification is increasingly 
popular among scientists because the resulting compounds tend 
to have the higher antioxidant ability and increased lipophilic 
properties than FA itself (Adeyemi et al., 2018). The alkyl 
ferulates are esterified ferulates that have been reported to have 
higher antioxidant activity in a membranous system (Anselmi 
et al., 2005), to prevent neurodegenerative disorders (Anselmi et 
al., 2004), to possess anticancer potential (Sultana, 2012), and to 
possess the ability to penetrate the skin using intercellular pathways 
(Murakami et al., 2000). Alkyl ferulates include ferulic propyl, 
which could be single-bonded (-anyl), double-bonded (-enyl), or 
Figure 4. Superoxide anion scavenging activity of propionyl ferulate, ferulic 
acid, and L-ascorbic acid (standard). Data are expressed as the mean of 
three replicates ± SEM. α is significant at p < 0.05 versus ferulic acid and/or 
L-ascorbic acid.
Figure 5. Total antioxidant capacity of propionyl ferulate and ferulic acid 
expressed as a number of gram equivalents of L-ascorbic acid. Data are 
expressed as the mean of three replicates ± SEM. α is significant at p < 0.05 
versus ferulic acid.
Figure 6. Percentage membrane stabilizing activity of ferulic acid, propionyl 
ferulate, and acetylsalicylic acid (standard). Data are expressed as the mean of 
three replicates ± SEM. α is significant at p < 0.05 versus ferulic acid and/or 
acetylsalicylic acid.
Scheme 1. Synthesis of PF. 
Adeyemi et al. / Journal of Applied Pharmaceutical Science 10 (05); 2020: 097-103 101
triple-bonded (-ynyl). In this study, the focus was on the single-bond 
derivative, PF. The study showed that this structural modification 
of FA did not inhibit the antioxidant property of PF compared 
with FA but, rather, enhanced it. This supports the idea that the 
degree of freedom introduced by the FA modification, especially 
by esterification, may be indicative of rotation around the (C-O) 
bond, which could be a destabilizing factor that could increase their 
scavenging property (Calheiros et al., 2009; Zhang et al., 2010).
CONCLUSION
Findings revealed that PF had higher antioxidant 
activities than FA. The data indicate that structurally modifying 
FA can significantly improve its antioxidant activity. Additional 
investigations are warranted to explore the bioactive prospects 
of PF. 
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